| Metric | Q3 2026 | Q3 2025 |
|---|---|---|
| Revenue | 19,849.0 | 19,161.0 |
| Profit before tax | 2,370.0 | 2,418.0 |
| Net income | 1,579.0 | 1,643.0 |
| EPS (diluted, $ a share) | $7.27 | $6.96 |
A dash means the filing did not report that period. Growth is not shown when either period was a loss. Figures from the filing's XBRL data.
| Net income, year on year | -3.9% |
|---|---|
| Revenue, year on year | +3.6% |
10-Q filed with the SEC, NYSE: HCA. Figures from the filing's XBRL data; summary written with AI assistance from the filing.
HCA Healthcare, Inc.: key numbers
- Share price
- $511.78Close, Nov 16
- Market cap
- $107B
- Shares outstanding
- 208.89MLatest SEC cover page
- Sector
- Industrial Applications and Services
- Industry
- Services-General Medical & Surgical Hospitals, NECSIC 8062
Today's reference numbers, updated daily. Not a valuation or a recommendation.
More from HCA Healthcare, Inc.
All →HCA Healthcare SVP & Chief Nurse Executive Erica Rossitto Sells $1.77M of Stock
Erica Rossitto, SVP & Chief Nurse Executive, sold 3,500 shares of HCA Healthcare, Inc. at $505.81 a share, worth $1.77M in total on Nov 10, 2026. Shares held after the trade: 13,426 (-20.7%).
- Value
- $1.77M
- Shares
- 3,500
- Price
- $505.81
- Role
- SVP & Chief Nurse Executive
- Holding change
- -20.7%
- Trade date
- Nov 10, 2026
HCA Healthcare EVP and Chief Clinical Officer Michael J. Schlosser Sells $594K of Stock
Michael J. Schlosser, EVP and Chief Clinical Officer, sold 1,200 shares of HCA Healthcare, Inc. at $494.65 a share, worth $594K in total on Nov 4, 2026. Shares held after the trade: 1,443 (-45.4%).
- Value
- $594K
- Shares
- 1,200
- Price
- $494.65
- Role
- EVP and Chief Clinical Officer
- Holding change
- -45.4%
- Trade date
- Nov 4, 2026
HCA Healthcare EVP and COO Jon M. Foster Sells $15.9M of Stock
Jon M. Foster, EVP and COO, sold 31,713 shares of HCA Healthcare, Inc. at $491.98 to $514.07 a share (average $500.98) in 8 transactions, worth $15.9M in total between Nov 4, 2026 and Nov 6, 2026. Shares held after the trade: 10,000 (-12.9%).
- Value
- $15.9M
- Shares
- 31,713
- Average price
- $500.98
- Role
- EVP and COO
- Holding change
- -12.9%
- Trade date
- Nov 4, 2026 to Nov 6, 2026
HCA Healthcare $6.5B Debt Financing with CSC Delaware Trust Company
HCA Healthcare's subsidiary, HCA Inc., completed a massive $6.5 billion public offering of senior notes across seven different tranches with maturities ranging from 2028 to 2056. The notes are guaranteed on a senior unsecured basis by HCA Healthcare, Inc. and were issued under a shelf registration statement to manage the company's long-term capital structure.
- Value
- $6.5B
- Counterparty
- CSC Delaware Trust Company
- Term
- through 2056
HCA Healthcare $1.2B Debt Financing with Mizuho Securities USA LLC
HCA Healthcare's subsidiary, HCA Inc., has commenced a public offering of senior unsecured notes to fund general corporate purposes. The company intends to use the proceeds to redeem $1.200 billion of its 4.500% senior notes due February 2027 and repay borrowings under its commercial paper program and credit facility.
- Value
- $1.2B
- Counterparty
- Mizuho Securities USA LLC
- Term
- through Feb 2027
HCA Healthcare Financial Results
HCA Healthcare reported third quarter 2026 revenues of $19.85 billion, a 3.6% increase year-over-year, despite an estimated $400 million headwind from an unfavorable payer mix shift. The company also declared a quarterly cash dividend of $0.78 per share and indicated that full-year results are expected to be in the upper half of its previously issued guidance range.
- Term
- Q3 2026
“I have often mentioned that HCA has strong staying power because of our scale, the important role we play in providing critical services to communities, and our disciplined culture. Despite the challenges brought about by federal policy changes this year, our colleagues have continued to provide high-quality care to patients, and we believe HCA Healthcare is positioned to end the year positively.”
Sam Hazen, Chief Executive Officer of HCA Healthcare